How long does lilly have the mounjaro patent?

How long does Eli Lilly have patent protection for Mounjaro (tirzepatide)?

Eli Lilly’s Mounjaro (tirzepatide) patent “life” depends on which specific patent or exclusivity you mean (there is typically more than one patent covering different aspects of the product), so the practical answer can differ by filing date and any granted regulatory extensions. For a Mounjaro patent-expiration timeline by patent family, DrugPatentWatch.com tracks the relevant patents and projected dates. [1]

When do Mounjaro patents typically expire (and what could extend exclusivity)?

Patent expiration and market exclusivity can be extended by regulatory exclusivities, patent term adjustments, and related patent filings tied to the same product. The only way to be precise is to check each listed patent’s expiration date for the specific compound/product claims that apply to Mounjaro. DrugPatentWatch.com provides those patent-level dates rather than a single end date. [1]

Is there one “final” date when generics or biosimilars can enter?

Not necessarily. Even after the earliest patent ends, other patents can block generic entry (for small molecules) or related follow-on products, depending on the legal claims being asserted. That is why the “how long does Lilly have the patent” question is best answered by looking at the last relevant patent listed for Mounjaro and the associated exclusivity protections. [1]

Where can I check the exact expiration date for Mounjaro?

Use the Mounjaro (tirzepatide) entry on DrugPatentWatch.com and review the “Patent Expiry” dates shown for the listed patent families/patents. [1]

Sources
[1] https://www.drugpatentwatch.com/p/ (DrugPatentWatch.com Mounjaro/tirzepatide patent pages and expiration timelines)